Drug Shortage Report for LANTUS

Last updated on 2025-07-05 History
Report ID 260407
Drug Identification Number 02251930
Brand name LANTUS
Common or Proper name INSULIN GLARGINE
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 3 mL
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2025-06-16
Actual start date 2025-06-16
Estimated end date Unknown
Actual end date 2025-07-04
Shortage status Resolved
Updated date 2025-07-05
Company comments Supply delay. The shortage is only applicable to the cartridge product at this time. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-07-05 English Compare
v7 2025-07-04 French Compare
v6 2025-07-04 English Compare
v5 2025-06-17 French Compare
v4 2025-06-17 English Compare
v3 2025-06-17 English Compare
v2 2025-06-16 French Compare
v1 2025-06-16 English Compare

Showing 1 to 8 of 8